Vance Bray is a Rheumatology/Immunology physician affiliated with Denver Arthritis Clinic. OpenAlex indexes 13 publications with 229 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
Telephone
303-394-2828Provider last certified this registry record 6 Sept 2023.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20242 payments
- ABBVIE INC.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
73.1%TNF inhibitor28.9%Golimumab85%Infliximab15%Humira(Cf) Pen0%Simponi0%Enbrel Sureclick0%Enbrel0%Humira(Cf)0%Humira Pen0%Part D + Part B<11 patientsInterleukin-6 Receptor Antagonist26.1%Tocilizumab100%Part B, office-administered≥11 patients+ 7 more classes in this area
Musculoskeletal
18.5%RANK Ligand Inhibitor13%Denosumab100%Part B, office-administered≥125 patientsOther drugs affecting bone structure and mineralization5%Romosozumab-aqqg100%Part B, office-administered≥11 patients+ 7 more classes in this area
Dermatology
5.5%Corticosteroid5.5%Methylprednisolone acetate84%Methylprednisolone sodium succinate14%Methylprednisolone3%Part D + Part B≥56 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rheumatoid arthritis, new standards of care: nursing implications of infliximab
Journal of Orthopaedic Nursing
2004
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”